EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Study of World Health Organization Recommended Smallpox Vaccine to Prevent Monkeypox

Reas Najla Anugrah, Ahsanal Kasasiah

JURNAL KESMAS DAN GIZI (JKG) · 30.04.2026 · 8 (2) · 1164-1173

DOI: 10.35451/0ejez036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JURNAL KESMAS DAN GIZI (JKG), online erschienen am 30.04.2026. Verfasst von Reas Najla Anugrah und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Monkeypox is a zoonotic disease caused by the monkeypox virus (MPXV) from the Orthopoxvirus genus and has shown a global increase in cases since 2022. Currently, no specific vaccine is available; however, smallpox vaccines provide cross-protection and are recommended by the World Health Organization (WHO) for prevention.

Objective

This review aims to compare the efficacy and safety of WHO-recommended smallpox vaccines (MVA-BN, LC16m8, and ACAM2000) in preventing monkeypox.

Methods

This literature review searched Google Scholar and Publish or Perish with the keywords “monkeypox vaccine”, “MVA-BN,” “LC16,” “ACAM2000,” “efficacy,” and “safety.” Articles published between 2015 and 2025 were included. Of 155 identified records, 9 met the inclusion criteria and were analyzed.

Results

All vaccines were effective in preventing monkeypox through humoral and cellular immune responses. MVA-BN showed the highest efficacy and best safety profile, while LC16m8 provided long-term protection with mild adverse effects. ACAM2000 was effective but associated with mild cardiovascular adverse events, limiting its use in certain populations.

Conclusion

WHO-recommended smallpox vaccines are effective and relatively safe, with MVA-BN considered the most optimal option. Further development of monkeypox-specific vaccines using mRNA and DNA technologies is needed, as these platforms allow more specific antigen targeting and may enhance immune response and safety.

Zitieren

APA

Anugrah, R. N., & Kasasiah, A. (2026). Comparative Study of World Health Organization Recommended Smallpox Vaccine to Prevent Monkeypox. JURNAL KESMAS DAN GIZI (JKG), 8(2), 1164-1173. https://doi.org/10.35451/0ejez036

Vancouver

Anugrah RN, Kasasiah A. Comparative Study of World Health Organization Recommended Smallpox Vaccine to Prevent Monkeypox. JURNAL KESMAS DAN GIZI (JKG). 2026;8(2):1164-1173. doi:10.35451/0ejez036

BibTeX
@article{Anugrah2026,
  author = {Anugrah, Reas Najla and Kasasiah, Ahsanal},
  title = {Comparative Study of World Health Organization Recommended Smallpox Vaccine to Prevent Monkeypox},
  journal = {JURNAL KESMAS DAN GIZI (JKG)},
  year = {2026},
  volume = {8},
  number = {2},
  pages = {1164--1173},
  doi = {10.35451/0ejez036}
}
Kostenlos starten →